Very Low Oxygen Concentration (0.1%) Reveals Two FDCP-Mix Cell Subpopulations That Differ by Their Cell Cycling, Differentiation and P27KIP1 Expression
Overview
Affiliations
Oxygen (O(2)) concentrations in bone marrow vary from 4% in capillaries to <0.1% in subendosteum, in which hematopoietic stem cells reside in specific niches. Culture at low O(2) concentrations (3, 1 and 0.1%) influences hematopoietic stem and progenitor cells survival, proliferation and differentiation, depending on their level of differentiation. Culture of human CD34(+) cells at low O(2) concentrations (O(2) ≤3%) maintains stem cell engraftment potential better than at 20% O(2) (NOD/Scid xenograft model). In contrast, progenitors disappear from cultures at/or <1% O(2) concentrations. A very low O(2) concentration (0.1%) induces CD34(+) quiescence in G(0). The exploration of molecules and mechanisms involved in hematopoietic stem and progenitor cells' quiescence and differentiation related to low O(2) concentrations is unfeasible with primary CD34(+) cells. Therefore, we performed it using murine hematopoietic nonleukemic factor-dependent cell Paterson (FDCP)-Mix progenitor cell line. The culture of the FDCP-Mix line at 0.1% O(2) induced in parallel G(0) quiescence and granulo-monocytic differentiation of most cells, whereas a minority of undifferentiated self-renewing cells remained in active cell cycle. Hypoxia also induced hypophosphorylation of pRb and increased the expression of p27(KIP1), the two proteins that have a major role in the control of G(0) and G(1) to S-phase transition.
Rasouli M, Fattahi R, Nuoroozi G, Zarei-Behjani Z, Yaghoobi M, Hajmohammadi Z Cell Tissue Bank. 2023; 25(1):195-215.
PMID: 37365484 DOI: 10.1007/s10561-023-10099-9.
Runx2 overexpression promotes bone repair of osteonecrosis of the femoral head (ONFH).
Xu H, Liu X, Yang L, Ning Y, Xu L, Sun D Mol Biol Rep. 2023; 50(6):4769-4779.
PMID: 37029290 PMC: 10209270. DOI: 10.1007/s11033-023-08411-7.
Labat V, Bayard E, Refeyton A, Huart M, Avalon M, Debeissat C Biomolecules. 2022; 12(4).
PMID: 35454129 PMC: 9028139. DOI: 10.3390/biom12040540.
Vlaski-Lafarge M, Labat V, Brandy A, Refeyton A, Duchez P, Rodriguez L Front Oncol. 2020; 10:713.
PMID: 32528878 PMC: 7247845. DOI: 10.3389/fonc.2020.00713.
Tusa I, Cheloni G, Poteti M, Gozzini A, DeSouza N, Shan Y Stem Cell Reports. 2018; 11(4):929-943.
PMID: 30245209 PMC: 6178886. DOI: 10.1016/j.stemcr.2018.08.016.